OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiota and microbiota-derived metabolites in cardiovascular diseases
Xiaofeng Chen, Hua Zhang, Sichong Ren, et al.
Chinese Medical Journal (2023) Vol. 136, Iss. 19, pp. 2269-2284
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Depression and coronary heart disease: mechanisms, interventions, and treatments
Linjie Xu, Xu Zhai, Dazhuo Shi, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 21

Gut microbiota-derived metabolites and chronic inflammatory diseases
Alejandra Vargas, Benjamin L. Robinson, Kevin Houston, et al.
Exploration of Medicine (2025)
Open Access | Times Cited: 1

Shenmai injection revives cardiac function in rats with hypertensive heart failure: involvement of microbial-host co-metabolism
Lin Li, Senjie Zhong, Jiahao Ye, et al.
BMC Complementary Medicine and Therapies (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1

Nutrition and Lifestyle Interventions in Managing Dyslipidemia and Cardiometabolic Risk
Hasan Berisha, Reham Hattab, Laura Comi, et al.
Nutrients (2025) Vol. 17, Iss. 5, pp. 776-776
Open Access | Times Cited: 1

The Mediterranean Diet, Its Microbiome Connections, and Cardiovascular Health: A Narrative Review
Vincenzo Abrignani, Andrea Salvo, Gaetano Pacinella, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4942-4942
Open Access | Times Cited: 6

Recent Advances in Microbiota-Associated Metabolites in Heart Failure
Sepiso K. Masenga, Joreen P. Povia, Propheria C. Lwiindi, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2313-2313
Open Access | Times Cited: 14

Berberine promotes the degradation of phenylacetic acid to prevent thrombosis by modulating gut microbiota
Hao-Jian Zhang, Jie Fu, Hang Yu, et al.
Phytomedicine (2024) Vol. 128, pp. 155517-155517
Closed Access | Times Cited: 5

The Aging Heart in Focus: The Advanced Understanding of Heart Failure with Preserved Ejection Fraction
Zhe-Wei Zhang, Yibin Wang, Xiangqi Chen, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102542-102542
Closed Access | Times Cited: 4

Gas-producing potential of intestinal microbiota representatives in patients with post-infarction cardiosclerosis
Yu. V. Chervinets, E. V. Stepanova, В. М. Червинец, et al.
Parodontologiya (2025)
Closed Access

Study on the mechanism of action of Jingfang mixture against carrageenan-induced thrombosis in rats based on the gut-liver axis
Wenting Ni, Yunyu Wang, Shirong Li, et al.
Research Square (Research Square) (2025)
Closed Access

The gut microbiota and its role in the development of cardiovascular disease
Carlos Escobar, Xavier Aldeguer, David Vivas, et al.
Expert Review of Cardiovascular Therapy (2025), pp. 1-12
Closed Access

Trymethylamine-N-oxide, a gut-derived metabolite, induces myofibroblastic activation of valvular interstitial cells through endoplasmic reticulum stress
Samanvitha Deepthi Sudi, Shankar Suresh, Tamara N. Kolli, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Gut microbiota-derived metabolites: Potential targets for cardiorenal syndrome
Yu-Chen Lai, Yujie Zhu, Xihui Zhang, et al.
Pharmacological Research (2025), pp. 107672-107672
Open Access

Indoleacetylglutamine Pathway Is a Potential Biomarker for Cardiovascular Diseases
Khaled Naja, Najeha Anwardeen, Mashael Al-Shafai, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 377-377
Open Access

Intestinal flora was associated with occurrence risk of chronic non-communicable diseases
Guoheng Jiang, Hongyu Li, Linjun Xie, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 11
Closed Access

WITHDRAWN: Study on the mechanism of action of Jingfang mixture against carrageenan-induced thrombosis in rats based on the gut-liver axis
Wenting Ni, Yunyu Wang, Shirong Li, et al.
Research Square (Research Square) (2025)
Closed Access

The heart of the matter: How gut microbiota-targeted interventions influence cardiovascular diseases
Mohammad Abavisani, Pourya Tafti, Niloofar Khoshroo, et al.
Pathology - Research and Practice (2025), pp. 155931-155931
Closed Access

Thrombosis and Thrombotic Risk in Athletes
C. Miele, Cristina Mennitti, Alessandro Gentile, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4881-4881
Open Access | Times Cited: 3

Gut–Kidney–Heart: A Novel Trilogy
Mario Caldarelli, Laura Franza, Pierluigi Rio, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3063-3063
Open Access | Times Cited: 6

Gut matters in microgravity: potential link of gut microbiota and its metabolites to cardiovascular and musculoskeletal well-being
Zeinab Ibrahim, Naveed Ahmed Khan, Ruqaiyyah Siddiqui, et al.
Nutrition & Metabolism (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2

Gut microbiota’s causative relationship with peripheral artery disease: a Mendelian randomization study
Yu Tian, Guanqun Yao, Loren Skudder‐Hill, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 1

Intermediate molecular weight–fucosylated chondroitin sulfate from sea cucumber Cucumaria frondosa is a promising anticoagulant targeting intrinsic factor IXa
Yuanjie Liu, Rongfeng Li, Song Lin, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 131952-131952
Closed Access | Times Cited: 1

The Role of Gut Dysbiosis in Cardiovascular Diseases
Vikrant Rai, Devendra K. Agrawal
Advances in biochemistry in health and disease (2024), pp. 477-494
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top